Article
Impact of CYP2D6 genotype on postoperative tramadol analgesia.
Pain - 1 Sept 2003
Stamer Ulrike M, Lehnen Katja, Höthker Fabienne, Bayerer Bettina, Wolf Stephanie, Hoeft Andreas, Stuber Frank
Abstract excerpt
Genetic polymorphisms result in absent enzyme activity of CYP2D6 (poor metabolizers, PM) in about 10% of the Caucasian population. This study investigates whether the PM genotype has an impact on the response to tramadol analgesia in postoperative patients. A prospective study design was used and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
